294 employees
Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.
1994
$60M
from 2 investors over 2 rounds
Agenus raised $60M on February 14, 2017
Investors: Incyte
Agenus raised $10M on August 4, 2009
Investors: Hudson Capital Management LLC